A Nonhuman Primate Model of the Hematopoietic Acute Radiation Syndrome Plus Medical Management
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
The development of medical countermeasures against the hematopoietic subsyndrome of the acute radiation syndrome requires well characterized and validated animal models. The model must define the radiation dose- and time-dependent relationships for mortality and major signs of morbidity to include other organ damage that may contribute to morbidity and mortality. Herein, the authors define these parameters for a nonhuman primate exposed to total body radiation and administered medical management. A blinded, randomized study (n = 48 rhesus macaques) determined the lethal dose-response relationship using bilateral 6 MV linear accelerator photon radiation to doses in the range of 7.20 to 8.90 Gy at 0.80 Gy min(-1). Following irradiation, animals were monitored for complete bloodcounts, body weight, temperature, diarrhea, and hydration status for 60 d. Animals were administered medical management consisting of intravenous fluids, prophylactic antibiotics, blood transfusions, anti-diarrheals, analgesics, and nutrition. The primary endpoint was survival at 60 d post-irradiation; secondary endpoints included hematopoietic-related parameters, number of transfusions, incidence of documented infection, febrile neutropenia, severity of diarrhea, mean survival time of decedents, and tissue histology. The study defined an LD30/60 of 7.06 Gy, LD50/60 of 7.52 Gy, and an LD70/60 of 7.99 Gy with a relatively steep slope of 1.13 probits per linear dose. This study establishes a rhesus macaque model of the hematopoietic acute radiation syndrome and shows the marked effect of medical management on increased survival and overall mean survival time for decedents. Furthermore, following a nuclear terrorist event, medical management may be the only treatment administered at its optimal schedule.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer
Hughes, W. T., Armstrong, D., Bodey, G. P., Bow, E. J., Brown, A. E., Calandra, T., Feld, R., Pizzo, P. A., Rolston, K. V. I., Shenep, J. L., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/339215 · Cited by 1,964
Waselenko, J. K., MacVittie, T. J., Blakely, W. F., Pesik, N., Wiley, A. L., Dickerson, W. E., Tsu, H., Confer, D. L., Coleman, C. N., Seed, T., et al. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-12-200406150-00015 · Cited by 766 · cited 4×
“These measures will be similar for personnel exposed to myelosuppressive and potentially lethal doses of radiation (MacVittie et al. 1996; Ricks et al. 2002; Nagayama et al. 2002; Waselenko et al. 2004; Baranov et al. 1994; Ortiz et al. 2003; Konchalovsky 2010).”
BackgroundSelf-citationDOSE RESPONSE RELATIONSHIPS FOR ACUTE IONIZING-RADIATION LETHALITY
Anno, G. H., Young, R. W., Bloom, R. M., & Mercier, J. R. (2003) · Health Physics · doi:10.1097/00004032-200305000-00001 · Cited by 148 · cited 3×
“…selected weapon-exposed cohorts, Chernobyl victims, and controlled animal data) suggests that the most likely LD50/60 of 4.00 Gy for the human population can be raised to 6.00 MLTD with the benefit of supportive care (Anno et al. 2003; Baranov et al. 1996; Baranov et al. 1990; Guskova et al. 1990).”
BackgroundInfluential
Cited by
Filgrastim improves survival in lethally irradiated nonhuman primates
Farese, A. M., Cohen, M. V., Katz, B. P., Smith, C. P., Gibbs, A., Cohen, D. M., & MacVittie, T. J. (2013) · Radiation Research · doi:10.1667/rr3049.1 · Cited by 187
“We previously determined the effect of medical management on the lethal dose-response relationship for the H-ARS in nonhuman primates and herein, used the estimated LD50/60 for NHP administered medical management to assess the efficacy of filgrastim (38).”
Self-citationAnimal models for acute radiation syndrome drug discovery
Singh, V. K., Newman, V. L., Berg, A. N., & MacVittie, T. J. (2015) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2015.1023290 · Cited by 139
“In mice, development of bone marrow syndrome is significantly faster, with half the population dying within 30 days of irradiation (LD50/30); for larger animal models, a 45- to 60-day period is considered (LD50/60) [83].”
BackgroundSelf-citationPegfilgrastim improves survival of lethally irradiated nonhuman primates
Hankey, K. G., Farese, A. M., Blaauw, E. C., Gibbs, A. M., Smith, C. P., Katz, B. P., Tong, Y., Prado, K. L., & MacVittie, T. J. (2015) · Radiation Research · doi:10.1667/rr13940.1 · Cited by 129
“88) that was estimated from a previous study that defined the radiation dose-response relationship for H-ARS in NHP exposed to 6 MV linac-derived photon radiation and administered medical management (41).”
BackgroundMethodSelf-citationWong, K., Chang, P. Y., Fielden, M., Downey, A. M., Bunin, D., Bakke, J., Gahagen, J., Iyer, L., Doshi, S., Wierzbicki, W., et al. (2020) · International Journal of Radiation Biology · doi:10.1080/09553002.2019.1625488 · Cited by 57
Farese, A. M., Brown, C. R., Smith, C. P., Gibbs, A. M., Katz, B. P., Johnson, C. S., Prado, K. L., & MacVittie, T. J. (2014) · Health Physics · doi:10.1097/hp.0b013e3182a4dd2c · Cited by 56
Self-citationClayton, N. P., Khan-Malek, R. C., Dangler, C. A., Zhang, D., Ascah, A., Gains, M., Gardner, B., Mockbee, C., Keutzer, J. M., McManus, J., et al. (2020) · Radiation Research · doi:10.1667/rade-20-00131.1 · Cited by 52
Farese, A. M., Bennett, A. W., Gibbs, A. M., Hankey, K. G., Prado, K., Jackson, W., & MacVittie, T. J. (2019) · Health Physics · doi:10.1097/hp.0000000000000878 · Cited by 49
Self-citationFarese, A. M., Booth, C., Tudor, G. L., Cui, W., Cohen, E. P., Parker, G. A., Hankey, K. G., & MacVittie, T. J. (2021) · Health Physics · doi:10.1097/hp.0000000000001451 · Cited by 11
Self-citation
Metadata
- Authors
- Farese, A. M., Cohen, M. V., Katz, B. P., Smith, C. P., Jackson, W., Cohen, D. M., & MacVittie, T. J.
- Venue
- Health Physics
- Published
- 2012-10
- Volume
- 103
- Issue
- 4
- Pages
- 367-382
- ISSN
- 0017-9078 (ISSN-L)
- OpenAlex
- W2044229897
- Cited by
- 134
- References
- 3
- FWCI
- 6.90
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.